ZyVersa Therapeutics Inc (NASDAQ:ZVSA) has a beta value of 0.46 and has seen 1.02 million shares traded in the recent trading session. The company, currently valued at $2.04M, closed the recent trade at $0.82 per share which meant it lost -$0.13 on the day or -14.27% during that session. The ZVSA stock price is -1143.9% off its 52-week high price of $10.20 and -3.66% below the 52-week low of $0.85. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.66 million shares traded. The 3-month trading volume is 891.43K shares.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Sporting -14.27% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ZVSA stock price touched $0.82 or saw a rise of 22.64%. Year-to-date, ZyVersa Therapeutics Inc shares have moved -23.10%, while the 5-day performance has seen it change -13.66%. Over the past 30 days, the shares of ZyVersa Therapeutics Inc (NASDAQ:ZVSA) have changed -33.19%. Short interest in the company has seen 44416.0 shares shorted with days to cover at 0.69.
ZVSA Dividends
ZyVersa Therapeutics Inc is expected to release its next earnings report on 2024-Nov-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
Insiders own 0.25% of the company shares, while shares held by institutions stand at 3.23% with a share float percentage of 3.24%. Investors are also buoyed by the number of investors in a company, with ZyVersa Therapeutics Inc having a total of 8.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 0.20% shares in the company for having 4.95 shares of worth $4137.0 while later fund manager owns 1.39 shares of worth $1165.0 as of Dec 31, 2024, which makes it owner of about 0.06% of company’s outstanding stock.
